1
|
Carrillo AJ, Rivera P, Walker RT, Farina LL, Benjamin EJ. Aorto-left atrial fistula secondary to aortic infective endocarditis in a dog with a bicuspid aortic valve. J Vet Cardiol 2024; 53:13-19. [PMID: 38565003 DOI: 10.1016/j.jvc.2024.02.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2023] [Revised: 02/20/2024] [Accepted: 02/22/2024] [Indexed: 04/04/2024]
Abstract
An 11-year-old male neutered English Bulldog was presented for evaluation of thrombocytopenia, acute onset of ataxia, and vomiting. A new murmur was auscultated on physical examination. Transthoracic echocardiographic examination revealed a bicuspid aortic valve, vegetative lesions on the aortic valve, and continuous shunting from the aortic root to the left atrium through an aorta to left atrial fistula. The dog was euthanized due to guarded prognosis and critical condition. Pathological examination confirmed presence of bicuspid aortic valve, aorto-left atrial fistula, and aortic infective endocarditis. Antemortem blood culture revealed two unusual organisms: Achromobacter xylosoxidans and Fusobacterium mortiferum.
Collapse
Affiliation(s)
- A J Carrillo
- Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, 2015 SW 16th Ave, PO Box 100116, Gainesville, FL 32610-0116, USA
| | - P Rivera
- Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, 2015 SW 16th Ave, PO Box 100116, Gainesville, FL 32610-0116, USA
| | - R T Walker
- Department of Comparative, Diagnostic, and Population Medicine, College of Veterinary Medicine, University of Florida, 2015 SW 16th Ave, PO Box 100123, Gainesville, FL 32610-0123, USA
| | - L L Farina
- Department of Comparative, Diagnostic, and Population Medicine, College of Veterinary Medicine, University of Florida, 2015 SW 16th Ave, PO Box 100123, Gainesville, FL 32610-0123, USA
| | - E J Benjamin
- Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, 2015 SW 16th Ave, PO Box 100116, Gainesville, FL 32610-0116, USA.
| |
Collapse
|
2
|
Proppe C, Rivera P, Beltran E, Hill E. Neuromuscular and mean force changes during a fatiguing bout of exercise with and without blood flow restriction. Comparative Exercise Physiology 2022. [DOI: 10.3920/cep220023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2022]
Abstract
Surface electromyography (EMG) and mean force can be used to identify motor unit excitation and fatigue. Low-load resistance training with blood flow restriction (LL+BFR) may result in earlier fatigue and maximal muscle fibre recruitment compared to low-load resistance training (LL). The purpose of this investigation was to examine EMG and force responses during LL versus LL+BFR. Thirteen males (mean ± standard deviation = 24±4 years) completed a bout (1×30) of leg extension muscle actions at 30% of their 1 repetition maximum LL and LL+BFR while force, EMG amplitude, and EMG mean power frequency (EMG MPF) were recorded. EMG amplitude increased (74.2%) and EMG MPF decreased (22.6%) similarly during both conditions. There was no significant difference in mean force during the first 3 repetitions between LL+BFR (477.3±132.3 N) and LL (524.3±235.1 N) conditions, but mean force was lower during the last 3 repetitions for LL+BFR (459.7±179.3 N) compared to LL (605.4±276.4 N). The results of the present study indicated that a fatiguing bout of leg extension muscle actions performed LL and LL+BFR elicited similar neuromuscular responses. There was a significant difference in mean force during the last 3 repetitions (LL>LL+BFR) that may have been due to differences in the time spent near peak force.
Collapse
Affiliation(s)
- C. Proppe
- University of Central Florida, 12494 University Boulevard 320L, Orlando, FL 32816, USA
| | - P. Rivera
- University of Central Florida, 12494 University Boulevard 320L, Orlando, FL 32816, USA
| | - E. Beltran
- University of Central Florida, 12494 University Boulevard 320L, Orlando, FL 32816, USA
- Florida Space Institute, Research Pkwy, Orlando, FL 32826, USA
| | - E. Hill
- University of Central Florida, 12494 University Boulevard 320L, Orlando, FL 32816, USA
- Florida Space Institute, Research Pkwy, Orlando, FL 32826, USA
| |
Collapse
|
3
|
Pandya S, Le T, Demissie S, Zaky A, Arjmand S, Patel N, Moko L, Garces J, Rivera P, Singer K, Fedoriv I, Garcia Z, Kennedy J, Makkapati B, Mukherjee I, Szerszen A, Gross J, Glinik G, Younan D. The Association of Gender and Mortality in Geriatric Trauma Patients. Healthcare (Basel) 2022; 10:healthcare10081472. [PMID: 36011129 PMCID: PMC9407800 DOI: 10.3390/healthcare10081472] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2022] [Revised: 07/27/2022] [Accepted: 07/28/2022] [Indexed: 11/16/2022] Open
Abstract
The association of gender with mortality in trauma remains a subject of debate. Geriatric trauma patients have a higher risk of mortality compared to younger patients. We sought to evaluate the association of gender with mortality in a group of geriatric trauma patients presenting to an academic level 1 trauma center (trauma center designated by New York State capable of handling the most severe injuries and most complex cases). Methods: We performed a retrospective review of geriatric trauma patients who were admitted to our trauma center between January 2018 and December 2020. Data collected included vital signs, demographics, injury, and clinical characteristics, laboratory data and outcome measures. The study controlled for co-morbidities, injury severity score (ISS), and systolic blood pressure (SBP) in the ED. Multivariable logistic regression analysis was performed to evaluate the association of gender and mortality. Results: 4432 geriatric patients were admitted during the study period, there were 1635 (36.9%) men and 3859 (87.2%) were White with an average age of 81 ± 8.5 years. The mean ISS was 6.7 ± 5.4 and average length of stay was 6 ± 6.3 days. There were 165 deaths. Male gender (OR 1.94, 95% CI 1.38 to 2.73), ISS (OR 1.12, 95% CI 1.09 to 1.14), Emergency Department SBP less than 90 mmHg (OR 6.17, 95% CI 3.17 to 12.01), and having more than one co-morbidity (OR 2.28, 95% CI 1.55 to 3.35) were independently predictive of death on multivariable logistic regression analysis. Conclusion: Male gender, Emergency Department systolic blood pressure less than 90 mmHg, having more than one co-morbidity, and injury severity are independent predictors of mortality among geriatric trauma patients.
Collapse
Affiliation(s)
- Shreya Pandya
- The Department of Surgery, Division of Acute Care Surgery, Staten Island University Hospital, Staten Island, New York, NY 10305, USA
| | - Timothy Le
- The Department of Surgery, Division of Acute Care Surgery, Staten Island University Hospital, Staten Island, New York, NY 10305, USA
| | - Seleshi Demissie
- Biostatistics Unit, Feinstein Institutes for Medical Research, Staten Island University Hospital, Staten Island, New York, NY 10305, USA
| | - Ahmed Zaky
- Department of Anesthesia, The University of Alabama in Birmingham, Birmingham, AL 35294, USA
| | - Shadi Arjmand
- The Department of Surgery, Division of Acute Care Surgery, Staten Island University Hospital, Staten Island, New York, NY 10305, USA
| | - Nikhil Patel
- The Department of Surgery, Division of Acute Care Surgery, Staten Island University Hospital, Staten Island, New York, NY 10305, USA
| | - Lilamarie Moko
- The Department of Surgery, Division of Acute Care Surgery, Staten Island University Hospital, Staten Island, New York, NY 10305, USA
| | - Juan Garces
- The Department of Surgery, Division of Acute Care Surgery, Staten Island University Hospital, Staten Island, New York, NY 10305, USA
| | - Paula Rivera
- The Department of Surgery, Division of Acute Care Surgery, Staten Island University Hospital, Staten Island, New York, NY 10305, USA
| | - Kiara Singer
- The Department of Surgery, Division of Acute Care Surgery, Staten Island University Hospital, Staten Island, New York, NY 10305, USA
| | - Ivan Fedoriv
- The Department of Surgery, Division of Acute Care Surgery, Staten Island University Hospital, Staten Island, New York, NY 10305, USA
| | - Zachery Garcia
- The Department of Surgery, Division of Acute Care Surgery, Staten Island University Hospital, Staten Island, New York, NY 10305, USA
| | - James Kennedy
- The Department of Surgery, Division of Acute Care Surgery, Staten Island University Hospital, Staten Island, New York, NY 10305, USA
| | - Bhavana Makkapati
- The Department of Surgery, Division of Acute Care Surgery, Staten Island University Hospital, Staten Island, New York, NY 10305, USA
| | - Indraneil Mukherjee
- Department of Surgery, Division of Minimally Invasive Surgery, Staten Island University Hospital, Staten Island, New York, NY 10305, USA
| | - Anita Szerszen
- Department of Medicine, Division of Geriatric Medicine, Staten Island University Hospital, Staten Island, New York, NY 10305, USA
| | - Jonathan Gross
- Department of Orthopedics, Staten Island University Hospital, Staten Island, New York, NY 10305, USA
| | - Galina Glinik
- The Department of Surgery, Division of Acute Care Surgery, Staten Island University Hospital, Staten Island, New York, NY 10305, USA
| | - Duraid Younan
- The Department of Surgery, Division of Acute Care Surgery, Staten Island University Hospital, Staten Island, New York, NY 10305, USA
- Correspondence:
| |
Collapse
|
4
|
Venturas M, Prats J, Querol E, Zabalegui A, Fabrellas N, Rivera P, Casafont C, Cuzco C, Frías CE, Olivé MC, Pérez-Ortega S. Lived Experiences of Hospitalized COVID-19 Patients: A Qualitative Study. Int J Environ Res Public Health 2021; 18:ijerph182010958. [PMID: 34682704 PMCID: PMC8535666 DOI: 10.3390/ijerph182010958] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 07/27/2021] [Revised: 09/21/2021] [Accepted: 10/12/2021] [Indexed: 01/05/2023]
Abstract
The COVID-19 pandemic has resulted in many hospitalized patients and deaths worldwide. Coronavirus patients were isolated from their relatives and visits were banned to prevent contagion. This has brought about a significant change in deeply rooted care habits in Mediterranean and Latin American countries where the family normally accompanies vulnerable hospitalized patients. The aim of this qualitative study was to examine the hospitalization experience of COVID-19 patients and their family members. A phenomenological qualitative approach was used. Data collection included inductive, in-depth interviews with 11 COVID-19 hospitalized patients. The mean age of patients was 55.4 years and 45% were female. Nearly 50% required Intensive Care Unit (ICU) admission. Ten meaningful statements were identified and grouped in three themes: Positive and negative aspects of the care provided, the patient’s perspective, and perception of the experience of the disease. In conclusion, COVID-19 patients, aware of the severity of the pandemic, were very adaptable to the situation and had full confidence in health professionals. Patient isolation was perceived as necessary. Technology has helped to maintain communication between patients and relatives.
Collapse
Affiliation(s)
- Montserrat Venturas
- Hospital Clinic Barcelona, 08036 Barcelona, Spain; (M.V.); (J.P.); (E.Q.); (A.Z.); (P.R.); (C.C.); (C.C.); (C.E.F.)
- School of Nursing, University of Barcelona, 08036 Barcelona, Spain; (N.F.); (M.C.O.)
| | - Judith Prats
- Hospital Clinic Barcelona, 08036 Barcelona, Spain; (M.V.); (J.P.); (E.Q.); (A.Z.); (P.R.); (C.C.); (C.C.); (C.E.F.)
| | - Elena Querol
- Hospital Clinic Barcelona, 08036 Barcelona, Spain; (M.V.); (J.P.); (E.Q.); (A.Z.); (P.R.); (C.C.); (C.C.); (C.E.F.)
| | - Adelaida Zabalegui
- Hospital Clinic Barcelona, 08036 Barcelona, Spain; (M.V.); (J.P.); (E.Q.); (A.Z.); (P.R.); (C.C.); (C.C.); (C.E.F.)
- School of Nursing, University of Barcelona, 08036 Barcelona, Spain; (N.F.); (M.C.O.)
| | - Núria Fabrellas
- School of Nursing, University of Barcelona, 08036 Barcelona, Spain; (N.F.); (M.C.O.)
| | - Paula Rivera
- Hospital Clinic Barcelona, 08036 Barcelona, Spain; (M.V.); (J.P.); (E.Q.); (A.Z.); (P.R.); (C.C.); (C.C.); (C.E.F.)
| | - Claudia Casafont
- Hospital Clinic Barcelona, 08036 Barcelona, Spain; (M.V.); (J.P.); (E.Q.); (A.Z.); (P.R.); (C.C.); (C.C.); (C.E.F.)
- School of Nursing, University of Barcelona, 08036 Barcelona, Spain; (N.F.); (M.C.O.)
| | - Cecilia Cuzco
- Hospital Clinic Barcelona, 08036 Barcelona, Spain; (M.V.); (J.P.); (E.Q.); (A.Z.); (P.R.); (C.C.); (C.C.); (C.E.F.)
- School of Nursing, University of Barcelona, 08036 Barcelona, Spain; (N.F.); (M.C.O.)
| | - Cindy E. Frías
- Hospital Clinic Barcelona, 08036 Barcelona, Spain; (M.V.); (J.P.); (E.Q.); (A.Z.); (P.R.); (C.C.); (C.C.); (C.E.F.)
- School of Nursing, University of Barcelona, 08036 Barcelona, Spain; (N.F.); (M.C.O.)
| | - Maria Carmen Olivé
- School of Nursing, University of Barcelona, 08036 Barcelona, Spain; (N.F.); (M.C.O.)
| | - Silvia Pérez-Ortega
- Hospital Clinic Barcelona, 08036 Barcelona, Spain; (M.V.); (J.P.); (E.Q.); (A.Z.); (P.R.); (C.C.); (C.C.); (C.E.F.)
- School of Nursing, University of Barcelona, 08036 Barcelona, Spain; (N.F.); (M.C.O.)
- Correspondence:
| |
Collapse
|
5
|
Casafont C, Fabrellas N, Rivera P, Olivé-Ferrer MC, Querol E, Venturas M, Prats J, Cuzco C, Frías CE, Pérez-Ortega S, Zabalegui A. Experiences of nursing students as healthcare aid during the COVID-19 pandemic in Spain: A phemonenological research study. Nurse Educ Today 2021; 97:104711. [PMID: 33418340 PMCID: PMC7744273 DOI: 10.1016/j.nedt.2020.104711] [Citation(s) in RCA: 69] [Impact Index Per Article: 23.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/24/2020] [Revised: 11/19/2020] [Accepted: 12/01/2020] [Indexed: 05/07/2023]
Abstract
BACKGROUND The coronavirus disease (COVID-19) pandemic has caused a worldwide health and social crisis directly impacting the healthcare system. Hospitals had to rearrange its structure to meet clinical needs. Spain has been experiencing a shortage of working nurses. Student nurses in their last year at university were employed to help the National Health System respond to the COVID-19 crisis. AIM The aim of this study was to explore and understand the experience of nursing students' roles as healthcare aid in responding to the COVID-19 crisis. METHODS A qualitative phenomenology design was used to explore undergraduate nursing students' perceptions of their experiences as HAs during the COVID-19 outbreak. Open face-to-face interviews were conducted to nursing students (n = 10) in May 2020. Data was analyzed using the hermeneutic interpretative approach. RESULTS All participants were women aged between 21 and 25 years. Seven main themes emerged: learning, ambivalent emotions and adaptation were classified at a personal level; teamwork, patient communication, and unclear care processes were categorized under hospital structure; and coping mechanisms were part of external factors. CONCLUSIONS Orientation, follow-up, and emotional support in crisis situations are key to unexperienced healthcare workers overcoming stressful emotions. Previous academic education and training may help novice future nurses feel more confident about their tasks and responsibilities as well as improve patient outcomes, resource management, and staff safety.
Collapse
Affiliation(s)
- Claudia Casafont
- Hospital Clinic of Barcelona, Spain; University of Barcelona (Campus Clinic Nursing School), Spain
| | - Núria Fabrellas
- University of Barcelona (Campus Clinic Nursing School), Spain
| | | | | | | | - Montserrat Venturas
- Hospital Clinic of Barcelona, Spain; University of Barcelona (Campus Clinic Nursing School), Spain
| | | | - Cecilia Cuzco
- Hospital Clinic of Barcelona, Spain; University of Barcelona (Campus Clinic Nursing School), Spain
| | - Cindy E Frías
- Hospital Clinic of Barcelona, Spain; University of Barcelona (Campus Clinic Nursing School), Spain
| | - Silvia Pérez-Ortega
- Hospital Clinic of Barcelona, Spain; University of Barcelona (Campus Clinic Nursing School), Spain
| | - Adelaida Zabalegui
- Hospital Clinic of Barcelona, Spain; University of Barcelona (Campus Clinic Nursing School), Spain.
| |
Collapse
|
6
|
Rivera P, Savage K, Ball A. A Systematic Approach to Spanish Neuropsychological Evaluation: Case Report with a Mexican Woman in an Outpatient Setting. Arch Clin Neuropsychol 2019. [DOI: 10.1093/arclin/acz029.58] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Objective
The following case will demonstrate a systematic approach to neuropsychological evaluation with Spanish-speaking individuals, which includes creating a suitable test battery, interpreting results with appropriate normative samples, and incorporating personal history.
Case Description
61-year-old, right-handed, Mexican female with 2 years of formal education, and with a recent history of subarachnoid hemorrhage with hydrocephalus. She was referred by her social worker and primary care provider to discern whether the reported cognitive complaints were due to a neurocognitive condition or depression.
Diagnostic Impressions and Outcomes
The evaluation was administered entirely in Spanish and some exams were modified to accommodate her limited literacy skills. She exhibited deficits in executive functioning, verbal fluency, and memory. Emotional testing revealed moderate depression with anxious distress, which she attributed to significant changes in everyday life. Her family informed us that she was the “matriarch of the family” and worked as a farm field truck driver, with significant difficulties/lack of engagement in both of these roles. Therefore, diagnoses of probable major vascular neurocognitive disorder and major depressive disorder with anxious distress were assigned. With this information, her providers were able to connect the family with community resources.
Discussion
The Hispanic population continues to be the fastest growing demographic in the United States. As more clinicians will work with members of this ethnicity in outpatient settings, it is important that they incorporate culturally-relevant factors in their approach to testing and interpretation of results. Nonetheless, this case demonstrates the current challenges and limitations, including modification of exams, differences in educational system that underlie test construction, and patient’s history. Recommendations for future areas of study and practice will also be discussed.
Collapse
|
7
|
Rivera P, Martos-Moreno GÁ, Barrios V, Suárez J, Pavón FJ, Chowen JA, Rodríguez de Fonseca F, Argente J. A novel approach to childhood obesity: circulating chemokines and growth factors as biomarkers of insulin resistance. Pediatr Obes 2019; 14:e12473. [PMID: 30350467 DOI: 10.1111/ijpo.12473] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/18/2018] [Revised: 08/10/2018] [Accepted: 08/15/2018] [Indexed: 01/01/2023]
Abstract
BACKGROUND Insulin resistance (IR) in children with obesity constitutes a risk factor that should be precisely diagnosed to prevent further comorbidities. OBJECTIVE Chemokines were evaluated to identify novel predictors of IR with clinical application. METHODS We analysed the levels of cytokines (tumour necrosis factor [TNF] α and interleukins [ILs] 1β, 4, 6 and 10), chemokines (stromal cell derived factor 1α, monocyte chemoattract protein [MCP] 1, eotaxin and fractalkine) and growth factors (brain-derived neurotrophic factor, pro-fibrotic platelet-derived growth factor [PDGF-BB] and insulin-like growth factor 1) in serum of prepubertal children with obesity (61 girls/59 boys, 50% IR and 50% non-IR) and 32 controls. Factor analysis, correlation, binary logistic regression and receiver operating characteristic analysis of combined biomarkers were used to validate their capability for preventive interventions of IR. RESULTS Changes in MCP1, eotaxin, IL1β and PDGF-BB were observed in IR children with obesity. Bivariate correlation between stromal cell derived factor 1α, MCP1, eotaxin, TNFα, brain-derived neurotrophic factor and/or PDGF-BB explained the high variance (65.9%) defined by three components related to inflammation and growth that contribute towards IR. The combination of leptin, triglyceride/high-density lipoprotein, insulin-like growth factor 1, TNFα, MCP1 and PDGF-BB showed a sensitivity and specificity of 93.2% for the identification of IR. The percentage of correct predictions was 89.6. CONCLUSIONS Combined set of cytokines, adipokines and chemokines constitutes a model that predicts IR, suggesting a potential application in clinical practice as biomarkers to identify children with obesity and hyperinsulinaemia.
Collapse
Affiliation(s)
- P Rivera
- Department of Pediatrics & Pediatric Endocrinology, Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid, Madrid, Spain
| | - G Á Martos-Moreno
- Department of Pediatrics & Pediatric Endocrinology, Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid, Madrid, Spain.,Hospital de la Princesa Research Institute, Madrid, Spain.,Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutriciόn (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
| | - V Barrios
- Department of Pediatrics & Pediatric Endocrinology, Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid, Madrid, Spain.,Hospital de la Princesa Research Institute, Madrid, Spain.,Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutriciόn (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
| | - J Suárez
- Instituto de Investigación Biomédica de Málaga (IBIMA), UGC Salud Mental, Universidad de Málaga, Hospital Universitario Regional de Málaga, Málaga, Spain
| | - F J Pavón
- Instituto de Investigación Biomédica de Málaga (IBIMA), UGC Salud Mental, Universidad de Málaga, Hospital Universitario Regional de Málaga, Málaga, Spain
| | - J A Chowen
- Department of Pediatrics & Pediatric Endocrinology, Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid, Madrid, Spain.,Hospital de la Princesa Research Institute, Madrid, Spain.,Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutriciόn (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.,IMDEA Food Institute, CEIUAM+CSIC, Madrid, Spain
| | - F Rodríguez de Fonseca
- Instituto de Investigación Biomédica de Málaga (IBIMA), UGC Salud Mental, Universidad de Málaga, Hospital Universitario Regional de Málaga, Málaga, Spain.,Department of Psychobiology, Universidad Complutense de Madrid, Madrid, Spain
| | - J Argente
- Department of Pediatrics & Pediatric Endocrinology, Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid, Madrid, Spain.,Hospital de la Princesa Research Institute, Madrid, Spain.,Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutriciόn (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.,IMDEA Food Institute, CEIUAM+CSIC, Madrid, Spain
| |
Collapse
|
8
|
Belanger A, Hollyfield J, Yacovone G, Seppe A, Akulian J, Burks C, Rivera P, Dodd L, Long J, Haithcock B, Pecot C. P1.05-01 Incidence and Clinical Relevance of NSCLC Lymph Node Micro-Metastasis Detected by Staging EBUS-TBNA. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.752] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
9
|
Rivera P. MTE26.01 Onco-Pulmonologist. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
10
|
Al-Masni MA, Al-Antari MA, Park JM, Gi G, Kim TY, Rivera P, Valarezo E, Han SM, Kim TS. Detection and classification of the breast abnormalities in digital mammograms via regional Convolutional Neural Network. Annu Int Conf IEEE Eng Med Biol Soc 2018; 2017:1230-1233. [PMID: 29060098 DOI: 10.1109/embc.2017.8037053] [Citation(s) in RCA: 49] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
Automatic detection and classification of the masses in mammograms are still a big challenge and play a crucial role to assist radiologists for accurate diagnosis. In this paper, we propose a novel computer-aided diagnose (CAD) system based on one of the regional deep learning techniques: a ROI-based Convolutional Neural Network (CNN) which is called You Only Look Once (YOLO). Our proposed YOLO-based CAD system contains four main stages: mammograms preprocessing, feature extraction utilizing multi convolutional deep layers, mass detection with confidence model, and finally mass classification using fully connected neural network (FC-NN). A set of training mammograms with the information of ROI masses and their types are used to train YOLO. The trained YOLO-based CAD system detects the masses and classifies their types into benign or malignant. Our results show that the proposed YOLO-based CAD system detects the mass location with an overall accuracy of 96.33%. The system also distinguishes between benign and malignant lesions with an overall accuracy of 85.52%. Our proposed system seems to be feasible as a CAD system capable of detection and classification at the same time. It also overcomes some challenging breast cancer cases such as the mass existing in the pectoral muscles or dense regions.
Collapse
|
11
|
Decara J, Rivera P, Arrabal S, Vargas A, Serrano A, Pavón FJ, Dieguez C, Nogueiras R, Rodríguez de Fonseca F, Suárez J. Cooperative role of the glucagon-like peptide-1 receptor and β3-adrenergic-mediated signalling on fat mass reduction through the downregulation of PKA/AKT/AMPK signalling in the adipose tissue and muscle of rats. Acta Physiol (Oxf) 2018; 222:e13008. [PMID: 29193738 DOI: 10.1111/apha.13008] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2017] [Revised: 11/13/2017] [Accepted: 11/23/2017] [Indexed: 12/19/2022]
Abstract
AIM To explore the cooperation of GLP-1 receptor and β3-adrenergic receptor (β3-AR)-mediated signalling in the control of fat mass/feeding behaviour by studying the effects of a combined therapy composed of the GLP-1R agonist liraglutide and the β3-AR agonist CL316243. METHODS The study included the analysis of key mechanisms regulating lipid/cholesterol metabolism, and thermogenesis in brown (BAT) and epididymal white (eWAT) adipose tissues, abdominal muscle and liver of male rats. RESULTS CL316243 (1 mg kg-1 ) and liraglutide (100 μg kg-1 ) co-administration over 6 days potentiated an overall negative energy balance (reduction in food intake, body weight gain, fat/non-fat mass ratio, liver fat content, and circulating levels of non-essential fatty acids, triglycerides, very low-density lipoprotein-cholesterol and leptin). These effects were accompanied by increased plasma levels of insulin and IL6. We also observed increased gene expression of uncoupling proteins regulating thermogenesis in BAT/eWAT (Ucp1) and muscle (Ucp2/3). Expression of transcription factor and enzymes involved either in de novo lipogenesis (Chrebp, Acaca, Fasn, Scd1, Insig1, Srebp1) or in fatty acid β-oxidation (Cpt1b) was enhanced in eWAT and/or muscle but decreased in BAT. Pparα and Pparγ, essentials in lipid flux/storage, were decreased in BAT/eWAT but increased in the muscle and liver. Cholesterol synthesis regulators (Insig2, Srebp2, Hmgcr) were particularly over-expressed in muscle. These GLP-1R/β3-AR-induced metabolic effects were associated with the downregulation of cAMP-dependent signalling pathways (PKA/AKT/AMPK). CONCLUSION Combined activation of GLP-1 and β3-ARs potentiate changes in peripheral pathways regulating lipid/cholesterol metabolism in a tissue-specific manner that favours a switch in energy availability/expenditure and may be useful for obesity treatment.
Collapse
Affiliation(s)
- J. Decara
- Instituto de Investigación Biomédica de Málaga (IBIMA); UGC Salud Mental; Universidad de Málaga, Hospital Universitario Regional de Málaga; Málaga Spain
| | - P. Rivera
- Department of Endocrinology; Fundación Investigación Biomédica del Hospital Infantil Universitario Niño Jesús; Madrid Spain
| | - S. Arrabal
- Instituto de Investigación Biomédica de Málaga (IBIMA); UGC Salud Mental; Universidad de Málaga, Hospital Universitario Regional de Málaga; Málaga Spain
| | - A. Vargas
- Instituto de Investigación Biomédica de Málaga (IBIMA); UGC Salud Mental; Universidad de Málaga, Hospital Universitario Regional de Málaga; Málaga Spain
| | - A. Serrano
- Instituto de Investigación Biomédica de Málaga (IBIMA); UGC Salud Mental; Universidad de Málaga, Hospital Universitario Regional de Málaga; Málaga Spain
| | - F. J. Pavón
- Instituto de Investigación Biomédica de Málaga (IBIMA); UGC Salud Mental; Universidad de Málaga, Hospital Universitario Regional de Málaga; Málaga Spain
| | - C. Dieguez
- Department of Physiology; School of Medicine-CIMUS; University of Santiago De Compostela-Instituto De Investigación Sanitaria; Santiago De Compostela Spain
- CIBER OBN; Instituto de Salud Carlos III; Madrid Spain
| | - R. Nogueiras
- Department of Physiology; School of Medicine-CIMUS; University of Santiago De Compostela-Instituto De Investigación Sanitaria; Santiago De Compostela Spain
- CIBER OBN; Instituto de Salud Carlos III; Madrid Spain
| | - F. Rodríguez de Fonseca
- Instituto de Investigación Biomédica de Málaga (IBIMA); UGC Salud Mental; Universidad de Málaga, Hospital Universitario Regional de Málaga; Málaga Spain
| | - J. Suárez
- Instituto de Investigación Biomédica de Málaga (IBIMA); UGC Salud Mental; Universidad de Málaga, Hospital Universitario Regional de Málaga; Málaga Spain
- Departamento de Biología Celular; Genética y Fisiología; Facultad de Ciencias; IBIMA; Universidad de Málaga; Málaga Spain
| |
Collapse
|
12
|
Rivera P, Purroy F. [The level of knowledge regarding the concept of brain death among undergraduates at the Universitat de Lleida]. Rev Neurol 2017; 65:489-495. [PMID: 29178106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
INTRODUCTION Brain death is a death situation which is diagnosed by means of neurological criteria and is the ideal situation for organ donation, as, thanks to intensive care, the organs maintain their viability. Very few studies have analysed the knowledge that the population has about this situation. AIM To determine how much university students know about brain death by comparing the results between undergraduates pursuing a degree in medicine and those on other bachelor's degree courses. SUBJECTS AND METHODS A closed on-line survey was administered to undergraduate students at the Universitat de Lleida about their knowledge regarding the concept of brain death, donor legislation and willingness to donate. RESULTS The survey was answered by a total of 488 people, 192 (39.3%) from the degree in medicine. Only 164 (33.6%) were males. The mean age was 22.1 ± 4.4 years. Only 63 (12.9%) respondents defined brain death as death. While 19.1% replied correctly to the question about organ donation legislation, 79.7% said they would be willing to donate their organs. The level of knowledge was significantly higher in the later courses of the degree in medicine, although there was still plenty of room for improvement in this respect. Only 31.7% of sixth-year students had a good idea of the concept of brain death. CONCLUSION The extent of knowledge about brain death and legislation on organ donation is poor among university students, even in the degree in medicine. It would be advisable to design strategies aimed at improving this knowledge, especially among future healthcare professionals.
Collapse
Affiliation(s)
- P Rivera
- Hospital Universitari Arnau de Vilanova, 25006 Lleida, Espana
| | - F Purroy
- Hospital Universitari Arnau de Vilanova, 25006 Lleida, Espana
| |
Collapse
|
13
|
Al-Antari MA, Al-Masni MA, Metwally M, Hussain D, Valarezo E, Rivera P, Gi G, Park JM, Kim TY, Park SJ, Shin JS, Han SM, Kim TS. Non-local means filter denoising for DEXA images. Annu Int Conf IEEE Eng Med Biol Soc 2017; 2017:572-575. [PMID: 29059937 DOI: 10.1109/embc.2017.8036889] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Dual high and low energy images of Dual Energy X-ray Absorptiometry (DEXA) suffer from noises due to the use of weak amount of X-rays. Denoising these DEXA images could be a key process to enhance and improve a Bone Mineral Density (BMD) map which is derived from a pair of high and low energy images. This could further improve the accuracy of diagnosis of bone fractures, osteoporosis, and etc. In this paper, we present a denoising technique for dual high and low energy images of DEXA via non-local means filter (NLMF). The noise of dual DEXA images is modeled based on both source and detector noises of a DEXA system. Then, the parameters of the proposed NLMF are optimized for denoising utilizing the experimental data from uniform phantoms. The optimized NLMF is tested and verified with the DEXA images of the uniform phantoms and real human spine. The quantitative evaluation shows the improvement of Signal-to-Noise Ratio (SNR) for the high and low phantom images on the order of 30.36% and 27.02% and for the high and low real spine images on the order of 22.28% and 33.43%, respectively. Our work suggests that denoising via NLMF could be a key preprocessing process for clinical DEXA imaging.
Collapse
|
14
|
Pivot X, Spano JP, Espie M, Cottu P, Jouannaud C, Pottier V, Moreau L, Extra JM, Lortholary A, Rivera P, Spaeth D, Attar-Rabia H, Benkanoun C, Dima-Martinez L, Esposito N, Gligorov J. Patients' preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer study. Eur J Cancer 2017. [PMID: 28648618 DOI: 10.1016/j.ejca.2017.05.009] [Citation(s) in RCA: 41] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
HannaH (NCT00950300) and PrefHer (NCT01401166) studies validated the subcutaneous (H-s.c.) formulation of trastuzumab as effective and safe as intravenous (H-i.v.) and highly preferred by patients in early breast cancer. The present randomised MetaspHer trial (NCT01810393) is the first study assessing patient's preference in metastatic setting. METHODS Patients with HER2-positive metastatic breast cancer who completed a first line chemotherapy with trastuzumab and achieved a long-term response lasting more than 3 years were randomised to receive 3 cycles of 600-mg fixed-dose adjuvant H-s.c., followed by 3 cycles of standard H-i.v., or the reverse sequence. Primary end-point was overall preference for H-s.c. or H-i.v. at cycle six, assessed by Patient Preference Questionnaire (PPQ). Secondary end-points included healthcare professional (HCP) satisfaction; safety and tolerability; quality of life. RESULTS Hundred and thirteen patients were randomised and treated. H-s.c. was preferred by 79/92 evaluable intent-to-treat patients (85.9%, 95% confidence interval [CI; 78.8-93.0]; p < 0.001), 13/92 preferred H-i.v. (14.1%, 95% CI [7.0-21.3]). HCPs were most satisfied with H-s.c. (56/88 available data, 63.6%, [53.6-73.7]). On the safety population, adverse events occurred in 73 (67.6%) and 49 (44.1%) patients during the H-s.c. and H-i.v. periods, respectively; 7 (6.5%) and 4 (3.6%) were grade ≥ III, 3 (2.8%) and 2 (1.8%) were serious. CONCLUSION The safety was consistent with the known H-i.v. and H-s.c. profiles without safety concern raised. Definitively, patients preferred H-s.c. as reported in early stage by PrefHer study.
Collapse
Affiliation(s)
- X Pivot
- University Hospital Jean Minjoz, INSERM 1098, Besancon, France.
| | - J P Spano
- AP-HP Pitié-Salpêtrière-Charles Foix, UPMC Université Paris 06, Paris, France
| | - M Espie
- Hôpital Saint Louis, AP-HP, Paris, France
| | - P Cottu
- Institut Curie, Paris, France
| | | | - V Pottier
- Centre Leonard De Vinci, Dechy, France
| | - L Moreau
- Pôle Santé République - Clinique Clermont-Ferrand, Clermont Ferrand, France
| | - J M Extra
- Institut Paoli-Calmettes, Marseille, France
| | | | - P Rivera
- Institut Claudius-Regaud, Toulouse, France
| | - D Spaeth
- Gentilly Oncology Centre, Nancy, France
| | | | | | | | | | - J Gligorov
- APHP Tenon, Inserm U938, IUC-UPMC Sorbonne Université, Paris, France
| |
Collapse
|
15
|
Pivot X, Spano JP, Marc E, Cottu P, Jouannaud C, Pottier V, Moreau L, Extra JM, Lortholary A, Rivera P, Spaeth D, Attar-Rabia H, Benkamoun C, Dima-Martinez L, Esposito N, Gligorov J. Patient preference of trastuzumab administration (SC versus IV) in HER2-positive metastatic breast cancer: Results of the randomised Metaspher study. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw365.53] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
16
|
Rivera P, Seyler KL, Yu H, Schaibley JR, Yan J, Mandrus DG, Yao W, Xu X. Valley-polarized exciton dynamics in a 2D semiconductor heterostructure. Science 2016; 351:688-91. [DOI: 10.1126/science.aac7820] [Citation(s) in RCA: 501] [Impact Index Per Article: 62.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
17
|
McGurk R, Schreiber E, Das S, Zagar T, Green R, Lawrence M, Sheikh A, McCartney W, Rivera P, Marks L. TU-G-BRA-01: Assessing Radiation-Induced Reductions in Regional Lung Perfusion Following Stereotactic Radiotherapy for Lung Cancer. Med Phys 2015. [DOI: 10.1118/1.4925751] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
18
|
George L, Ramirez J, Rivera P, Ojeda A. C-24 * Shared Neuropsychological Mechanisms of Attention-Deficit/Hyperactivity Disorder and Eating Disorders. Arch Clin Neuropsychol 2014. [DOI: 10.1093/arclin/acu038.205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
19
|
Bernard-Marty C, Laborie S, Lapreses E, François CL, Rivera P, Salignon K, Loste F, Mourey L, Balardy L. Standardization of the geriatric assessment within the Midi-Pyrenees Unite de Coordination in Oncogeriatrie. J Geriatr Oncol 2013. [DOI: 10.1016/j.jgo.2013.09.093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
20
|
Rivera P, Akerlund-Denneberg N, Bergvall K, Kessler M, Rowe A, Willmann M, Persson G, Kastengren Fröberg G, Westberg S, von Euler H. Clinical efficacy and safety of a water-soluble micellar paclitaxel (Paccal Vet) in canine mastocytomas. J Small Anim Pract 2012. [PMID: 23190121 DOI: 10.1111/j.1748-5827.2012.01304.x] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVE To determine the clinical efficacy and safety of a cremophor-free formulation of paclitaxel (Paccal Vet, Oasmia Pharmaceuticals) in dogs with mast cell tumours. METHODS Paccal Vet was administered at a median dose of 145 (range, 135 to 150) mg/m(2) intravenously once every 21 days for three cycles to 29 dogs with macroscopic grade 2 or 3 mast cell tumour. Efficacy was assessed by tumour response (Response Evaluation Criteria in Solid Tumours version 1.0) and performance status score. Progression-free survival, quality of life and safety/adverse events were also evaluated. Clinical safety was assessed by clinicopathological analyses and recording of adverse events. RESULTS Complete or partial response was observed in 59% of dogs. Performance status score remained constant or improved for 20 dogs and decreased by one grade for 9 dogs. Median time to progression was 247 (range, 42 to 268) days. Expected, transient frequently subclinical adverse events (primarily grade 3/4 neutropenia and grade 1/2 leukopenia) were observed in the majority of dogs. Nine dogs were euthanased and one dog died due to disease progression. CLINICAL SIGNIFICANCE Paccal Vet appears to be a clinically safe and effective treatment for canine mast cell tumours. Further controlled confirmatory investigation is warranted.
Collapse
Affiliation(s)
- P Rivera
- Department of Clinical Sciences, Center of Clinical Comparative Oncology (C3O), Swedish University of Agricultural Sciences (SLU), SE-750 07, Uppsala, Sweden
| | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Malka D, Boige V, Faron M, Caramella C, Boucher E, Rivera P, De Baere T, Goéré D, Pignon J, Ducreux M. Hepatic Arterial Infusion (HAI) of Oxaliplatin Plus Intravenous (IV) Fluorouracil (FU), Leucovorin (LV) and Cetuximab for First-Line Treatment of Unresectable Colorectal Liver Metastases (CRLM): Final Results of a Multicenter Phase 2 Study (CHOICE). Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)33192-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
22
|
Romero-Zerbo SY, Garcia-Gutierrez MS, Suárez J, Rivera P, Ruz-Maldonado I, Vida M, Rodriguez de Fonseca F, Manzanares J, Bermúdez-Silva FJ. Overexpression of cannabinoid CB2 receptor in the brain induces hyperglycaemia and a lean phenotype in adult mice. J Neuroendocrinol 2012; 24:1106-19. [PMID: 22487302 DOI: 10.1111/j.1365-2826.2012.02325.x] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
It is well known that the endocannabinoid system, through cannabinoid CB1 receptor activation, has an important role in the main aspects of energy balance (i.e. food intake, energy expenditure and glucose and fat metabolism), orchestrating all the machinery involved in body weight control and energy homeostasis. A number of studies have revealed a crucial role of brain CB1 receptors in these processes. However, functional cannabinoid CB2 receptors have also been described in the brain, with no studies addressing their putative role in body weight control and glucose homeostasis. We have tested this hypothesis by analysing fasting-induced feeding, body weight, some hypothalamic neuropeptides, glucose tolerance and plasma hormones in an animal model specifically overexpressing CB2 receptors in the central nervous system. We found that specific overexpression of CB2 receptors in the brain promoted higher basal glucose levels, decreased fasting-induced feeding and, eventually, led to a lean phenotype and glucose intolerance. These findings could not be attributed to decreased locomotor activity, increased anxiety or depressive-like behaviours. The expression of relevant neuropeptides such as pro-opiomelanocortin and galanin in the arcuate nucleus of the hypothalamus was altered but not those of the CB1 receptor. Indeed, no changes in CB1 expression were found in the liver, skeletal muscle and adipose tissue. However, cannabinoid CB1 and CB2 receptor expression in the endocrine pancreas and glucagon plasma levels were decreased. No changes in plasma adiponectin, leptin, insulin and somatostatin were found. Taken together, these results suggest a role for central cannabinoid CB2 receptors in body weight control and glucose homeostasis.
Collapse
Affiliation(s)
- S Y Romero-Zerbo
- Laboratorio de Medicina Regenerativa, Instituto de Investigación Biomédica de Málaga (Ibima), Hospital Carlos Haya, Málaga, Spain
| | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Crespillo A, Alonso M, Vida M, Pavón FJ, Serrano A, Rivera P, Romero-Zerbo Y, Fernández-Llebrez P, Martínez A, Pérez-Valero V, Bermúdez-Silva FJ, Suárez J, de Fonseca FR. Reduction of body weight, liver steatosis and expression of stearoyl-CoA desaturase 1 by the isoflavone daidzein in diet-induced obesity. Br J Pharmacol 2012; 164:1899-915. [PMID: 21557739 DOI: 10.1111/j.1476-5381.2011.01477.x] [Citation(s) in RCA: 76] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
BACKGROUND AND PURPOSE The lack of safe and effective treatments for obesity has increased interest in natural products that may serve as alternative therapies. From this perspective, we have analysed the effects of daidzein, one of the main soy isoflavones, on diet-induced obesity in rats. EXPERIMENTAL APPROACH Rats made obese after exposure to a very (60%) high fat-content diet were treated with daidzein (50 mg·kg(-1)) for 14 days. The dose was selected on the basis of the acute effects of this isoflavone on a feeding test. After 14 days, animals were killed and plasma, white and brown adipose tissue, muscle and liver studied for the levels and expression of metabolites, proteins and genes relevant to lipid metabolism. KEY RESULTS A single treatment (acute) with daidzein dose-dependently reduced food intake. Chronic treatment (daily for 14 days) reduced weight gain and fat content in liver, accompanied by high leptin and low adiponectin levels in plasma. While skeletal muscle was weakly affected by treatment, both adipose tissue and liver displayed marked changes after treatment with daidzein, affecting transcription factors and lipogenic enzymes, particularly stearoyl coenzyme A desaturase 1, a pivotal enzyme in obesity. Expression of uncoupling protein 1, an important enzyme for thermogenesis, was increased in brown adipose tissue after daidzein treatment. CONCLUSIONS AND IMPLICATIONS These results support the use of isoflavones in diet-induced obesity, especially when hepatic steatosis is present and open a new field of use for these natural products.
Collapse
Affiliation(s)
- A Crespillo
- Laboratorio de Medicina Regenerativa, Hospital Carlos Haya, Fundación IMABIS, Pabellón de Gobierno, Málaga, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
von Euler H, Rivera P, Nyman H, Häggström J, Borgå O. A dose-finding study with a novel water-soluble formulation of paclitaxel for the treatment of malignant high-grade solid tumours in dogs. Vet Comp Oncol 2012; 11:243-55. [PMID: 22404965 DOI: 10.1111/j.1476-5829.2011.00314.x] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
A new formulation of water-soluble paclitaxel (Paccal® Vet) has been developed for canine cancer patients, without the need for pre-medication (traditionally required in non-water-soluble paclitaxel formulations). The objective of the study was to determine a clinically safe and efficacious dose of Paccal Vet and to estimate progression-free and overall survival and to evaluate single-dose pharmacokinetics in tumour-bearing dogs. A positive risk:benefit ratio was established for Paccal Vet administered at 150 mg m(-2) intravenous (IV) for three or more treatment cycles. Preliminary efficacy was demonstrated by best objective response rate (86%), median time to response (14 days) and median progression-free survival (131 days). Paccal Vet was associated with expected adverse events (AE) (e.g. myelosuppression), however the majority were transient, clinically silent and manageable. This is the first clinical report of a water-soluble formulation of paclitaxel suggesting successful administration and being safely used without pre-medication in dogs.
Collapse
Affiliation(s)
- H von Euler
- Department of Clinical Sciences, Division of Small Animal Clinical Sciences, Swedish University of Agricultural Sciences (SLU), Uppsala, Sweden
| | | | | | | | | |
Collapse
|
25
|
Antoine E, Dalenc F, Hebert C, Rivera P, Romieu G, Varoqueaux N, Guastalla JP, Namer M. Long-term survival in patients with HER2-positive metastatic breast cancer treated with trastuzumab as first-line therapy: Seven-year follow-up of the French Observational Hermine Study. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.617] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
26
|
Rivera P, Filleron T, Gladieff L, Delord J, Mery E, Roche H, Dalenc F. Efficacy of cetuximab plus platinum agent in advanced, triple-negative breast carcinoma: Results of a retrospective analysis. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e11581] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
27
|
Otth L, Wilson M, Fernández H, Otth C, Toledo C, Cárcamo V, Rivera P, Ruiz L. Isolation of Helicobacter pylori in gastric mucosa and susceptibility to five antimicrobial drugs in Southern chile. Braz J Microbiol 2011; 42:442-7. [PMID: 24031652 PMCID: PMC3769845 DOI: 10.1590/s1517-83822011000200005] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2010] [Accepted: 11/04/2010] [Indexed: 12/20/2022] Open
Abstract
Helicobacter pylori colonizes more than 50% of the world population thus, it is considered an important cause of gastric cancer. The aim of this study was to determine the isolation frequency of H. pylori in Southern Chile from patients with symptomatology compatible with gastritis or gastric ulcer and to correlate these findings with demographic parameters of infected patients and the susceptibility profiles of the isolated strains to the antimicrobial drugs used in the eradication treatments. A total of 240 patients were enrolled in the study. Each gastric biopsy was homogenized and seeded onto blood agar plates containing a selective antibiotics mixture (DENT supplement). Plates were incubated at 37° C in a microaerophilic environment for five days. The susceptibility profiles to amoxicillin, ciprofloxacin, clarithromycin, tetracycline and metronidazole were determined using the E-test method. H. pylori was isolated from 99 patients (41.3%) with slightly higher frequency in female (42% positive cultures) than male (40.2% positive cultures). With regard to age and educational level, the highest isolation frequencies were obtained in patients between 21-30 (55%) and 41-50 (52.6%) years old, and patients with secondary (43.9%) and university (46.2%) educational levels. Nineteen (21.6%) strains showed resistance to at least one antimicrobial drug. Tetracycline was the most active antimicrobial in vitro, whereas metronidazole was the less active. One strain (5.3%) showed resistance to amoxicillin, clarithomycin and metronidazole, simultaneously.
Collapse
Affiliation(s)
- Laura Otth
- Institute of Clinical Microbiology, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile
| | - Myra Wilson
- Institute of Clinical Microbiology, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile
| | - Heriberto Fernández
- Institute of Clinical Microbiology, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile
| | - Carola Otth
- Institute of Clinical Microbiology, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile
| | - Claudio Toledo
- Institute of Medical Specialties, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile
| | - Victoria Cárcamo
- Institute of Clinical Microbiology, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile
| | - Paula Rivera
- Institute of Clinical Microbiology, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile
| | - Luis Ruiz
- Institute of Clinical Microbiology, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile
| |
Collapse
|
28
|
Affiliation(s)
- P. Rivera
- Center of Clinical Comparative Oncology C3O, Department of Clinical Sciences, Division of Small Animals, Swedish University of Agricultural Sciences, Uppsala, Sweden
| | - H. von Euler
- Center of Clinical Comparative Oncology C3O, Department of Clinical Sciences, Division of Small Animals, Swedish University of Agricultural Sciences, Uppsala, Sweden
| |
Collapse
|
29
|
Delporte C, Backhouse N, Negrete R, Gallardo MC, Rivera P. Antiinflammatory and Antipyretic Activities of Spartidienedione Isolated from Psila spartioides. ACTA ACUST UNITED AC 2008. [DOI: 10.1076/phbi.34.3.179.13216] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Affiliation(s)
- C Delporte
- Departamento de Quimica Farmacologica y Toxicologica, Facultad de Ciencias Quimicas y Farmaceuticas, Universidad de Chile, P.O. Box 233, Santiago-l, Chile
- Departamento de Quimica, Facultad de Ciencias, Universidad de Chile, P.O. Box 653, Santiago, Chile
| | - N Backhouse
- Departamento de Quimica Farmacologica y Toxicologica, Facultad de Ciencias Quimicas y Farmaceuticas, Universidad de Chile, P.O. Box 233, Santiago-l, Chile
| | - R Negrete
- Departamento de Quimica Farmacologica y Toxicologica, Facultad de Ciencias Quimicas y Farmaceuticas, Universidad de Chile, P.O. Box 233, Santiago-l, Chile
| | - M C Gallardo
- Departamento de Quimica Farmacologica y Toxicologica, Facultad de Ciencias Quimicas y Farmaceuticas, Universidad de Chile, P.O. Box 233, Santiago-l, Chile
| | - P Rivera
- Departamento de Quimica Farmacologica y Toxicologica, Facultad de Ciencias Quimicas y Farmaceuticas, Universidad de Chile, P.O. Box 233, Santiago-l, Chile
| |
Collapse
|
30
|
Meister N, Shalaby T, von Bueren AO, Rivera P, Patti R, Oehler C, Pruschy M, Grotzer MA. Interferon-gamma mediated up-regulation of caspase-8 sensitizes medulloblastoma cells to radio- and chemotherapy. Eur J Cancer 2007; 43:1833-41. [PMID: 17627812 DOI: 10.1016/j.ejca.2007.05.028] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2006] [Revised: 04/12/2007] [Accepted: 05/29/2007] [Indexed: 11/24/2022]
Abstract
Loss of caspase-8 expression - which has been demonstrated in a subset of Medulloblastoma (MB) - might block important apoptotic signalling pathways and therefore contribute to treatment resistance. In this study, IFN-gamma mediated up-regulation of caspase-8 in human MB cells was found to result in chemosensitization to cisplatin, doxorubicin and etoposide, and sensitisation to radiation. These effects were more prominent in D425 and D341 MB cells (low basal caspase-8 expression) when compared to DAOY MB cells (high basal caspase-8 expression). IFN-gamma mediated chemosensitization and radiosensitization effects were reduced by treatment with the caspase-8 specific inhibitor z-IETD-fmk. Treatment of IFN-gamma resulted in activation of STAT1 in DAOY MB cells and to a lesser extent in D425, but not in D341, indicating that IFN-gamma acts in MB cells through STAT1-dependent and -independent signalling pathways. Taken together, our results demonstrate that IFN-gamma mediated restoration of caspase-8 in MB cells might enhance apoptotic pathways relevant to the response to chemo- and radiotherapy.
Collapse
Affiliation(s)
- N Meister
- Neuro-Oncology Program, University Children's Hospital of Zurich, Steinwiesstrasse 75, 8032 Zurich, Switzerland
| | | | | | | | | | | | | | | |
Collapse
|
31
|
D'cunja J, Shalaby T, Rivera P, von Büren A, Patti R, Heppner FL, Arcaro A, Rorke-Adams LB, Phillips PC, Grotzer MA. Antisense treatment of IGF-IR induces apoptosis and enhances chemosensitivity in central nervous system atypical teratoid/rhabdoid tumours cells. Eur J Cancer 2007; 43:1581-9. [PMID: 17446062 DOI: 10.1016/j.ejca.2007.03.003] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2006] [Revised: 11/28/2006] [Accepted: 03/05/2007] [Indexed: 02/04/2023]
Abstract
Central nervous system (CNS) atypical teratoid/rhabdoid tumours (AT/RT) are among the paediatric malignant tumours with the worst prognosis and fatal outcome. Insulin-like growth factor I receptor (IGF-IR) protects cancer cells from apoptosis induced by a variety of anticancer drugs and radiation. In the present study, IGF-IR was expressed in 8/8 primary AT/RT as detected by immunohistochemistry. Moreover, we found IGF-I and IGF-II mRNA in BT-16 CNS AT/RT cells and IGF-II mRNA in BT-12 CNS AT/RT cells, and autophosphorylated IGF-IR in both cell lines, indicating the potential presence of an autocrine/paracrine IGF-I/II/IGF-IR loop in CNS AT/RT. IGF-IR antisense oligonucleotide treatment of human CNS AT/RT cells resulted in significant down-regulation of IGF-IR mRNA and protein expression, induction of apoptosis, and chemosensitisation to doxorubicin and cisplatin. These studies provide evidence for the influence of IGF-IR on cellular responses to chemotherapy and raise the possibility that curability of selected CNS AT/RT may be improved by pharmaceutical strategies directed towards the IGF-IR.
Collapse
Affiliation(s)
- J D'cunja
- Neuro-Oncology Program, University Children's Hospital of Zurich, Steinwiesstrasse 75, CH-8032 Zurich, Switzerland
| | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Bevans MF, Marden S, Leidy NK, Soeken K, Cusack G, Rivera P, Mayberry H, Bishop MR, Childs R, Barrett AJ. Health-related quality of life in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2006; 38:101-9. [PMID: 16751786 DOI: 10.1038/sj.bmt.1705406] [Citation(s) in RCA: 77] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
Reduced-intensity conditioning allogeneic HSCT (RIC) has less regimen-related morbidity and mortality than myeloablative allogeneic HSCT (MT) offering allogeneic transplantation to patients otherwise excluded. Whether these advantages improve health-related quality of life (HRQL) is unknown. We examined the HRQL effects of RIC and MT in patients with hematological diseases pre-transplant (baseline), days 0, 30, 100, 1 and 2 years following HSCT. HRQL was measured using the Short Form-36 Health Survey and the Functional Assessment of Cancer Therapy - General and BMT. Data were analyzed using mixed linear modeling adjusting for baseline HRQL differences. Patients (RIC=41, MT=35) were predominately male (67%), in remission/stable disease (65%) with an Eastern Cooperative Oncology Group status <or=1 (97%). HRQL progressively improved (P<0.01) in both groups with higher scores at day 100 compared to days 0 and 30; there was no difference between groups during early recovery. At 2 years, all survivors (n=43) reported HRQL similar or better than baseline. Results suggest RIC and MT patients experience a similar pattern of HRQL improvement during early recovery. Two-year survivors report a return to baseline or better in HRQL by day 100, with the exception of physical health in MT patients.
Collapse
Affiliation(s)
- M F Bevans
- Department of Nursing, National Institutes of Health, Bethesda, MD 20892, USA.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Ríos M, Diago M, Rivera P, Tuset C, Cors R, García V, Carbonel P, Gonzalez C. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus. J Viral Hepat 2006; 13:177-81. [PMID: 16475993 DOI: 10.1111/j.1365-2893.2005.00673.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/09/2022]
Abstract
We studied the epidemiological, laboratory and histological characteristics of a group of patients with positive antibodies against hepatitis C virus (HCV) as determined by third-generation enzyme-linked immunosorbent assay (ELISA), and with indeterminate HCV antibody positivity as established by third-generation recombinant immunoblot assay (RIBA-3). The results obtained were compared with those recorded in a group of RIBA-3-positive patients. Both groups correspond to blood donors in whom the prevalence of hepatitis C is low. There were no statistically significant intergroup differences in mean age, or in the presence of infection risk factors. RNA positivity was much more frequent in the RIBA-positive group (71%vs 10%; P < 0.05), as was transaminase elevation during the 3 years of follow-up (54%vs 13%; P < 0.05). In 46% of the RIBA-indeterminate patients the liver biopsy proved normal, or only liver steatosis or minimal changes were detected, while 33% had persistent chronic hepatitis, and 21% showed active chronic hepatitis. A mean Knodell index score of 2.28 was recorded; 50% of the subjects showed no fibrosis, 46% grade 1 fibrosis (fibrous portal expansion), 4% grade 2 fibrosis (bridging fibrosis), and none grade 3 fibrosis (liver cirrhosis). In the RIBA-positive group, a greater percentage of patients had active chronic hepatitis, a greater Knodell index, and increased-grade fibrosis. It can be concluded that the RIBA-3-indeterminate group is epidemiologically similar to the RIBA-3-positive series, although with a lesser prevalence of laboratory test alterations, a lower viral replication index, and more likely to have benign disease - particularly in subjects without viral replication.
Collapse
Affiliation(s)
- M Ríos
- Hepatology Section, Service of Digestive Diseases, University General Hospital, Valencia, Spain.
| | | | | | | | | | | | | | | |
Collapse
|
34
|
Zamorano-Ponce E, Morales C, Ramos D, Sepúlveda C, Cares S, Rivera P, Fernández J, Carballo MA. Anti-genotoxic effect of Aloysia triphylla infusion against acrylamide-induced DNA damage as shown by the comet assay technique. Mutat Res 2006; 603:145-50. [PMID: 16413820 DOI: 10.1016/j.mrgentox.2005.11.009] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2004] [Revised: 11/15/2005] [Accepted: 11/17/2005] [Indexed: 11/29/2022]
Abstract
Aloysia triphylla a perennial, bushy plant originally from South America has long been used in traditional medicine. Its aqueous extract contains considerable amounts of polyphenolic compounds, namely flavonoids and phenolic acids. In view of the interest in natural phenolic compounds as antioxidant in preventive medicine, this study was undertaken to investigate the chemoprotective effects of cedron leaves infusion against the genetic damage induced by acrylamide (AA) by using the alkaline version of the comet assay technique. Mice were separated in nine groups (eight animals each): (I) untreated, (II) negative control, (III) treated with infusion of cedron leaves 5%, 20 days twice a day, (IV) treated with AA (5 mg/kg b.w.), (V) treated with AA (20 mg/kg b.w.), (VI) treated with AA (30 mg/kg b.w.), (VII) treated with AA (50 mg/kg b.w.), (VIII) pretreated with infusion and treated with AA (50 mg/kg b.w.) and (IX) positive control (cyclophosphamide, 20 mg/kg b.w.). Three hundred blast cells were digitally evaluated per animal from three different slides (100 each). Media of tail moment (TM) values were analyzed by ANOVA test. No statistical differences (p>0.05) were found between untreated animals, negative control and infusion-treated mice. A single dose of AA-induced genetic damage as revealed by a statistically significant increase in TM values (p<0.01). Pretreatment with infusion prior to AA injection significantly reduces the capacity of AA to induce genetic damage. In these conditions, tail moments values did not differ from data obtained in negative control (p>0.05) and exhibit statistical differences from animals treated only with AA (p<0.01). Cell viability was at least 90% in all cases as measured by the trypan blue exclusion method. The ferric reducing ability of plasma (FRAP) method reveals that the plasma of infusion-treated mice has a significantly higher antioxidant capacity than plasma from controls (p<0.01). The results suggest that the infusion could exerts an in vivo chemo protective action, probably due to its scavenging potency towards free radicals.
Collapse
Affiliation(s)
- E Zamorano-Ponce
- Laboratorio de Genética Toxicológica, Departamento de Ciencias Básicas, Facultad de Ciencias, Universidad del Bío-Bío, Casilla 447-Chillán, Chile.
| | | | | | | | | | | | | | | |
Collapse
|
35
|
Binz N, Shalaby T, Rivera P, Shin-ya K, Grotzer MA. Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells. Eur J Cancer 2005; 41:2873-81. [PMID: 16253503 DOI: 10.1016/j.ejca.2005.08.025] [Citation(s) in RCA: 70] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2005] [Revised: 08/05/2005] [Accepted: 08/16/2005] [Indexed: 11/23/2022]
Abstract
Neuroblastoma is a tumour derived from primitive cells of the sympathetic nervous system and is the most common extracranial solid tumour in childhood. Unfavourable tumours are characterised not only by structural changes, including 1p deletion and amplification of the MYCN proto-oncogene, but also by high telomerase activity. Telomeric G-rich single-stranded DNA can adopt in vitro an intramolecular quadruplex structure, which has been shown to inhibit telomerase activity. In this study, we examined telomestatin, a G-quadruplex interactive agent, for its ability to inhibit telomere maintenance of neuroblastoma cells. Telomere length was determined by the terminal restriction fragment method, telomerase activity was measured by a quantitative telomeric repeat amplification protocol, and the expression of human telomerase by quantitative real-time polymerase chain reaction (RT-PCR). Short-term treatment with telomestatin resulted in dose-dependent cytotoxicity and induction of apoptosis. Long-term treatment with telomestatin at non-cytotoxic, but still telomerase activity-inhibiting, concentrations resulted in telomere shortening, growth arrest and induction of apoptosis. These results suggest that the effect of telomestatin is dose-dependent and at least 2-fold. Prolonged low-dose treatment with telomestatin limits the cellular lifespan of NB cells through disruption of telomere maintenance.
Collapse
Affiliation(s)
- N Binz
- Department of Oncology, University Children's Hospital of Zurich, Steinwiesstrasse 75, Hospital, 8032 Zurich, Switzerland
| | | | | | | | | |
Collapse
|
36
|
Ruiz-León D, Rivera P, Brito I, Rodríguez M, Manríquez V. Crystal structure of isocalamendiol, C15H26O2 from Baccharis marginalis. Z KRIST-NEW CRYST ST 2005. [DOI: 10.1524/ncrs.2005.220.14.375] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
37
|
Galgay L, Swift S, Cusack G, Jones-Wells A, Rivera P, Chisholm L. Actualizing a wellness program and wellness room in the oncology setting: Getting a program through a large institution. Biol Blood Marrow Transplant 2005. [DOI: 10.1016/j.bbmt.2004.12.259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
38
|
Rivera P, Delord JP, Grosclaude P, Grand A, Bugat R. [Demography of oncologic practitioners working in France. Projection elements for the next 30 years]. Bull Cancer 2004; 91:271-7. [PMID: 15171052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/29/2023]
Abstract
In the early eighties, French medical regulatory authorities have decided to control the access to medical studies by restricting the number of admittances. From that date, the numerous clauses was unchanged, leading the physicians to observe a deep reduction in the number of young oncologists. The goal of this study was to define precisely the demography of French medical oncologists and the needs for new specialists. Our model used data from a wide range of sources was developed under the guidance of epidemiologists. We determined current and projected numbers and demographics of oncologists in France workforce from 2002 to 2032. The number of oncologists and physicians implicated in oncology (organ specialists, radiotherapists and paediatricians) entering the marked in the next few years will not be modified. Consequently, the number of physicians will dramatically decrease in the next 15 years resulting in a 25% global working-age population reduction. Our present analysis indicates that the number of oncologists will not be sufficient to meet future demand. Our data suggests that steps should be taken to stop the ongoing decline in the number of physicians involved in oncology and the decline of physicians in training. Consideration should be given to actions designed to increase the number of oncologists in practise in the years ahead.
Collapse
Affiliation(s)
- P Rivera
- Institut Claudius-Regaud, 20-24, rue du Pont Saint-Pierre, 31052 Toulouse
| | | | | | | | | |
Collapse
|
39
|
Rivera P, Tagle R, Mir S, González R. [Relationship between serum testosterone levels and prostatic cancer]. Actas Urol Esp 2003; 27:788-92. [PMID: 14735860] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/28/2023]
Abstract
INTRODUCTION The association between testosterone and prostate cancer badly is understood. The testosterone levels are not conclusive to distinguish benign prostate processes of malignant. The objective of our work is to determine the relation between levels of serum testosterone and prostate cancer. MATERIAL AND METHOD 38 patients with prostate cancer and a control group of 32 were studied in prospective form, with ages that fluctuated between the 50 and 80 years. The total and free testosterone was determined by radio-immunoensayo. The statistical analysis was descriptive inferential, with bands of 95% confidence. RESULTS The average values of total and free testosterone, were significantly smaller in patients with prostate cancer. Any correlation between gleason, prostate antigen and stage with testosterone, was not demonstrated. CONCLUSIONS Our work demonstrated that the testosterone is significantly smaller in the patients with prostate cancer that in the controls.
Collapse
Affiliation(s)
- P Rivera
- Unidad de Urología, Facultad de Medicina, Universidad de La Frontera, Temuco, Chile
| | | | | | | |
Collapse
|
40
|
Rivera P, Inostroza J, Treulén F. [Intraprostatic BCG vaccine in patients with prostatic cancer. Expression of interferon gamma and interleukin 4 (a preliminary study)]. Actas Urol Esp 2002; 26:351-5. [PMID: 12174744] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/26/2023]
Abstract
UNLABELLED The BCG treatment in the superficial bladder cancer is utilized since 1976. There are some animal experiences with BCG intraprostatic in dogs with prostatic cancer. GOAL determine if insitu BCG vaccine increase the prostatic immunity in patients with prostatic cancer. MATERIAL AND METHOD Three patients with D stage prostatic cancer where injected with 0.3-0.5 mg of BCG vaccine in the prostate. An histological picture where made in the some place before and after the injection. A RT-PCR study was made for gamma Interferon and Interleukin-4. RESULTS In two patients we observed gamma interferon expression (67%) respect the control, this produce an increase of the cytotoxic T lymphocytes, natural killer cells and macrophagos, that have antitumoral action. One patient increased the interleukin-4 that means production of T helper lymphocytes and B lymphocytes. There wasn't complications. CONCLUSIONS The BCG vaccine injected in prostatic tissue of patients with prostatic cancer, produces an increase of cytotoxic T lymphocytes and natural killer cells, with antitumoral action.
Collapse
Affiliation(s)
- P Rivera
- Servicio de Urología, Hospital Regional Temuco, Unidad de Urología, Departamento de Especialidades, Departamento de Ciencias Básicas, Universidad de la Frontera de Temuco
| | | | | |
Collapse
|
41
|
Boucher LJ, Rivera P. Metal phthalocyanine complexes. 1. Synthesis and properties of [Ru(ClPC)(py)2].cntdot.4py and [Ru(ClPC)(PPh3)2]. Inorg Chem 2002. [DOI: 10.1021/ic50208a081] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
42
|
Spaggiari GM, Carosio R, Pende D, Marcenaro S, Rivera P, Zocchi MR, Moretta L, Poggi A. NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46. Eur J Immunol 2001; 31:1656-65. [PMID: 11385609 DOI: 10.1002/1521-4141(200106)31:6<1656::aid-immu1656>3.0.co;2-v] [Citation(s) in RCA: 102] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Interleukin-2 (IL-2)-activated polyclonal or clonal NK cells lysed autologous antigen presenting cells (APC) through the engagement of the natural cytotoxicity receptors (NCR) NKp30 and NKp46. NK cell-mediated cytolysis of APC correlated with the surface density of these NCR. Indeed, NK cell clones bearing low amounts of NKp30 and NKp46 did not lyse autologous APC, whereas NK cell clones with bright expression of these NCR efficiently killed autologous APC. Upon masking of NKp30 or NKp46 by specific monoclonal antibodies a strong reduction (by 50%) of APC lysis could be detected and the complete inhibition was achieved by the simultaneous masking of these NCR. Interestingly, NK cell-mediated APC lysis was impaired by the phosphatidylinositol 3-kinase (PI-3 K) inhibitors LY294002 or wortmannin. Similarly, these drugs strongly reduced NK cell activation triggered by NKp30 or NKp46 in a re-directed killing assay as well as the activation of Akt/PKB, substrate of PI-3 K, induced by the engagement of these receptors. Altogether, these findings strongly suggest that NCR are responsible for the killing of autologous APC through the activation of PI-3 K.
Collapse
Affiliation(s)
- G M Spaggiari
- Laboratory of Immunology, National Cancer Research Institute, Genova, Italy
| | | | | | | | | | | | | | | |
Collapse
|
43
|
Pende D, Cantoni C, Rivera P, Vitale M, Castriconi R, Marcenaro S, Nanni M, Biassoni R, Bottino C, Moretta A, Moretta L. Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur J Immunol 2001; 31:1076-86. [PMID: 11298332 DOI: 10.1002/1521-4141(200104)31:4<1076::aid-immu1076>3.0.co;2-y] [Citation(s) in RCA: 74] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
NKG2D is a recently described activating receptor expressed by both NK cells and CTL. In this study we investigated the role of NKG2D in the natural cytolysis mediated by NK cell clones. The role of NKG2D varied depending on the type of target cells analyzed. Lysis of various tumors appeared to be exclusively natural cytotoxicity receptors (NCR) dependent. In contrast, killing of another group of target cells, including not only the epithelial cell lines HELA and IGROV-1, but also the FO-1 melanoma, the JA3 leukemia, the Daudi Burkitt lymphoma and even normal PHA-induced lymphoblasts, involved both NCR and NKG2D. Notably, NK cell clones expressing low surface densities of NCR (NCR(dull)) could lyse these tumors in an exclusively NKG2D-dependent fashion. Remarkably, not all of these targets expressed MICA/B, thus implying the existence of additional ligands recognized by NKG2D, possibly represented by GPI-linked molecules. Finally, we show that the engagement of different HLA class I-specific inhibitory receptors by either specific antibodies or the appropriate HLA class I ligand led to inhibition of NKG2D-mediated NK cell triggering.
Collapse
MESH Headings
- Animals
- Antibodies, Monoclonal/immunology
- Antibodies, Monoclonal/pharmacology
- Cells, Cultured
- Clone Cells/drug effects
- Clone Cells/immunology
- Cytotoxicity, Immunologic/drug effects
- Down-Regulation
- Epithelial Cells/immunology
- Epithelial Cells/pathology
- Flow Cytometry
- Histocompatibility Antigens Class I/immunology
- Humans
- Killer Cells, Natural/drug effects
- Killer Cells, Natural/immunology
- Killer Cells, Natural/metabolism
- Ligands
- Mice
- NK Cell Lectin-Like Receptor Subfamily K
- Neoplasms/immunology
- Neoplasms/pathology
- Phytohemagglutinins/immunology
- Phytohemagglutinins/pharmacology
- RNA, Messenger/analysis
- RNA, Messenger/genetics
- Receptors, Immunologic/genetics
- Receptors, Immunologic/immunology
- Receptors, Natural Killer Cell
- Transfection
- Tumor Cells, Cultured
Collapse
Affiliation(s)
- D Pende
- Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Rivas F, Rivera P, Hernández F, Hevia F, Guillén F, Tamayo G. [Helicobacter pylori antibiotic sensitivity by microdilution]. Rev Med Panama 2000; 25:19-23. [PMID: 15881743] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/02/2023]
Abstract
The gastric pathogen Helicobacter pylori has been recognized as the major aetiologic agent of chronic gastritis and peptic ulcers and also a risk factor for gastric cancer; eradication of H pylori prevents peptic ulcer recurrence and may also decrease the prevalence of gastric cancer in high risk populations around the world. Currently the only accepted indication for treatment is ulcer disease and maltosa, infected with Helicobacter pilory. However treatment is difficult and easily develops resistance. The elaboration of an antibiotic profile is recommended after a treatment failure. There is a lack of information in developing countries so the aim of this work was to determine the antibiotic profile of 51 strains isolated from patients gastric biopsies attended at Hospital San Juan de Dios in Costa Rica, using egg yolk broth and finding a resistance of 63.0% to metronidazole with a breakpoint of 8.0 microg/ml and 20.0% resistance to tetracycline (MIC1.0 microg/ml), 6.0% to clarithromicyn with a MIC of 0.125 microg/ml. There was no resistance to amoxicilin (MIC 0.015 microg/ml). The microdilution technique is very laborious, but highly reproducible with results accordingly to previous work, and we recommended it for the designing of therapeutical scheme.
Collapse
Affiliation(s)
- F Rivas
- De la Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica
| | | | | | | | | | | |
Collapse
|
45
|
Rivera P, Orio M, Hinostroza J, Venegas P, Pastor P, Gorena M, Lagos M, Pinochet R. [Our experience with 1 mg BCG vaccine instillation in T1 stage cancer of the bladder]. Actas Urol Esp 1999; 23:757-62. [PMID: 10608059 DOI: 10.1016/s0210-4806(99)72366-1] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
UNLABELLED We studied 67 patients with bladder cancer in stage T1, with terminated BCG treatment and in pursuit. No stage Ta neither carcinoma in situ was included. The protocol was: beginning of treatment upon retiring vesical catheter, instilation of 1 mg of liofilized BCG vaccine (16 x 10(6) bacilles) in 40-50 ml of intravesical saline solution. A weekly instilation during the first month. An instilation each 15 days during the second and third month and one monthly until complete 12 months of treatment. Also was carried out an study of T lymphocites and cytokines. RESULTS The average followup of the 67 patients treated was 51.3 months. 17 patients relapses (25.4%). A 33% were grade 3 and 27% grade 2. Like complications there was a case of inguinal TBC adenititis, 2 TBC prostatitis, 2 TBC cistitis and 5 cases of slight disuric syndrome. The study of subpopulations of lymphocites in peripheral blood demonstrated a significant increase of CD3 and CD4/CD8 ratio. The interleukin 2 measurement in serum also increased significantly after the BCG instilations. CONCLUSIONS Our protocol gets similar results to the higher doses, but with minimal complications diminishing the relapses of the tumors in stage T1. A monthly maintenance dose would help to maintain immunity.
Collapse
Affiliation(s)
- P Rivera
- Unidad de Urología, Facultad de Medicina, Universidad de La Frontera de Temuco-Chile
| | | | | | | | | | | | | | | |
Collapse
|
46
|
Abstract
In a double blind and placebo controlled study designed to investigate the effect of melatonin administration at 13:00 hr on menstrual characteristics, prolactin, and premenstrual syndrome-like symptoms during simulated eastward travel, it was noted that melatonin reduces or alleviates the stress associated with the simulated travel. Bright lights were utilized to simulate eastward movement across six time zones. Melatonin (10 mg) was given to healthy females for 5 consecutive days during the late follicular and early luteal phases of the menstrual cycle. Hourly blood samples, used for analysis of melatonin and prolactin levels, were obtained for 24 hr before entering the dose administration phase of the study and again on the last dose day. Volunteers also completed a profile of moods state questionnaire upon waking on each of 8 days which overlapped the in-house dose administration days. The placebo group showed a prolactin peak at 13:00 hr (dose time) on the last dose day/blood draw, while the melatonin group showed a prolactin peak at 15:00 hr. The prolactin peak at 13:00 hr is likely the result of stress, since stress is known to elicit the release of prolactin. The peak at 15:00 hr in the melatonin group was likely elicited by the administration of melatonin. Stress reduction in the melatonin group was supported by results from the profile of moods state questionnaire. The melatonin group consistently demonstrated scores indicative of less stress.
Collapse
|
47
|
Blanco D, Carol A, Rivera P, Hernández F, Hevia F, Guillén F, Duran S. [Evaluation of a fast urease test for the detection of Helicobacter pylori]. Acta Gastroenterol Latinoam 1999; 29:17-20. [PMID: 10435189] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/13/2023]
Abstract
Helicobacter Pylori colonize the gastric mucosa and their adaptation to this environment is related with its high activity urease. This enzyme hydrolyzes the gastric urea, neutralizing the acid environment of the bacteria. Based on that reaction numerous presumptive diagnosis tests, have been developed using a solution of urea (usually 6%) with a pH indicator (usually 0.05% fenol-red); nevertheless, the color changes are so light that some persons do not detect it. For that reason, a modification of that reaction was proposed using a mix of pH indicators (0.05% fenolred and 0.002 bromothymol blue) which induces a color change from light green to deep purple. Also, the reaction of urease was evaluated using only bromothymol blue. The reaction using fenol red as indicator showed the higher values for sensitivity of 58.8% and the specificity of 66.6%; whereas using only bromothymol-blue those values were 46 y 71.4% respectively. The efficiency of the test using fenol-red or the mix of this bromothymol- was 64.2 y 62.2%, respectively; however, the mix of indicators induce a change color easily detected, because of changes from ligh-green to deep-purple.
Collapse
Affiliation(s)
- D Blanco
- Facultad de Microbiología, Unidad de Microscopia Electrónica, Universidad de Costa Rica, San José, Costa Rica
| | | | | | | | | | | | | |
Collapse
|
48
|
Rivera P, Ferrer L, Tuset JA, Pamos S, López Mut J, Luján M, Tomé A, Medina E. [Non-aneurysmatic aortic dysphagia]. Gastroenterol Hepatol 1999; 22:345-8. [PMID: 10535207] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/14/2023]
Abstract
Esophageal compression by a vascular structure is a rare cause of dysphagia, the aberrant right subclavian artery being the most common congenital abnormality. Aortica dysphagia is usually observed in the elderly, especially in hypertensive women with cardiopathy and degenerative osteopathy. We report a 73-year-old woman with dysphagia, caused by a non-aneurysmatic aortic elongation, who presented progressive dysphagia, which ended in aphagia associated with heart failure. The diagnostic approach to these patients is discussed. The patient received cinitapride and, following treatment for heart failure, remains asymptomatic after a 3-year follow-up period, although manometric alterations persist.
Collapse
Affiliation(s)
- P Rivera
- Servicio de Aparato Digestivo, Hospital General Universitario, Valencia
| | | | | | | | | | | | | | | |
Collapse
|
49
|
Pamos S, Luján M, García V, Rivera P, Cors R, Diago M. [Focal nodular liver hyperplasia of atypical presentation]. Gastroenterol Hepatol 1998; 21:439-41. [PMID: 9882934] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/09/2023]
Abstract
Focal nodular hyperplasia is a benign hepatic tumor that usually appears in young women. Diagnosis of focal nodular hyperplasia is often incidental when an ultrasonography or computed tomography is performed by other reasons, because its course is generally asymptomatic; the presence of a central fibrous scar is characteristic. Management in focal nodular hyperplasia must be conservative, with ultrasonographic follow-up, and it only must be treated when patients are symptomatics or in case of tumoral enlargement. We report a case of FNH in which symptomatic presentation and the absence of central stellate scar in ultrasonography, computed tomography and magnetic resonance leads to a misdiagnostic of hepatic adenoma, that conditioned a surgical resection. The later examination was diagnostic of focal nodular hyperplasia.
Collapse
Affiliation(s)
- S Pamos
- Unidad de Hepatología, Hospital General Universitario, Valencia
| | | | | | | | | | | |
Collapse
|
50
|
Abstract
Jejunogastric intussusception is a rare complication of gastric surgery. We report a case in a 41-year-old woman subjected to gastrojejunostomy with truncal vagotomy 3 years before for pyloric stenosis. The jejunogastric intussusception was diagnosed by upper gastrointestinal series, ultrasonography, and computed tomography. Surgical management consisted of reduction and fixation. Treatment should be as early as possible to prevent gangrene of the invaginated segment.
Collapse
Affiliation(s)
- J V López-Mut
- Servicio de Radiodiagnóstico, Hospital General Universitario, Valencia, Spain
| | | | | | | | | |
Collapse
|